Harvard Drug Group Distributor of Generic Drugs Sold From One Private Equity Firm To Another

This is the largest generic focused distributor in the US with revenues of half a billion. The new owner also has other investments in drugs such as Amgen. BD

Harvard Drug Group, a distributor of generic drugs with nearly half-a-billion dollars in sales, has been purchased by a New York private equity firm for an undisclosed sum.

Court Square Capital Partners is the buyer, according to a statement from the seller, another private equity firm, H.I.G. Capital.

Founded in 1967, Harvard Drug is the largest independent generics-focused pharmaceutical distributor in the U.S., according to the statement. Since Harvard Drug is merely being traded from one private equity firm to another, the deal is unlikely to have much impact on its operations.

Harvard Drug has 400 employees and distribution facilities in Livonia, Michigan; Indianapolis, Indiana; and Decatur, Alabama.